Leukocyte adhesion deficiency II: therapy and genetic defect.
Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease which is caused by a defect in fucosylation of glycoconjugates. Hypofucosylated structures include ligands for the selectin family of adhesion molecules. This results in a leukocyte adhesion defect causing an immunodeficiency. In...
Κύριοι συγγραφείς: | Wild, M, Lühn, K, Marquardt, T, Vestweber, D |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2002
|
Παρόμοια τεκμήρια
-
The role of fucosylation in leukocyte adhesion deficiency II.
ανά: Vestweber, D, κ.ά.
Έκδοση: (2004) -
Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter.
ανά: Helmus, Y, κ.ά.
Έκδοση: (2006) -
The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter.
ανά: Lühn, K, κ.ά.
Έκδοση: (2001) -
Correction of leukocyte adhesion deficiency type II with oral fucose.
ανά: Marquardt, T, κ.ά.
Έκδοση: (1999) -
Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism.
ανά: Marquardt, T, κ.ά.
Έκδοση: (1999)